BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 324332)

  • 1. [Critical study of the treatment of lupic nephropathies].
    Mery JPh
    Ann Med Interne (Paris); 1977 Jan; 128(1):9-15. PubMed ID: 324332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systemic lupus erythematosus and end-stage chronic renal insufficiency. Therapeutic perspectives].
    Font J; Campistol JM
    Med Clin (Barc); 1989 Apr; 92(15):573-6. PubMed ID: 2666771
    [No Abstract]   [Full Text] [Related]  

  • 3. [Secondary glomerular nephropathies].
    Lesavre P
    Rev Prat; 2003 Nov; 53(18):2039-48. PubMed ID: 15008219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
    Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
    Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE.
    Ferluga D; Jerse M; Vizjak A; Hvala A; Rozman B; Kos-Golja M; Bren AF
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):692-701. PubMed ID: 11020959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of diffuse glomerulonephritis in systemic lupus erythematosus with a combination of anticoagulants, corticosteroids and immunosuppressors].
    Belovezhdov N
    Vutr Boles; 1985; 24(1):40-9. PubMed ID: 4024608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
    Zech P; Richard P; Blanc-Brunat N; Labeeuw M; Colon S; Pozet N; Dupont E; Fries D; Traeger J
    J Urol Nephrol (Paris); 1972 Dec; 78(12):987-93. PubMed ID: 4540960
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
    Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplantation glomerulonephritis: risk factors associated with kidney allograft loss.
    Ostrowska J; Pazik J; Lewandowski Z; Mróz A; Perkowska-Ptasińska A; Durlik M
    Transplant Proc; 2007 Nov; 39(9):2751-3. PubMed ID: 18021977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lupus nephropathy. Treatment with the indomethacin-hydroxychloroquine combination and comparison with corticoids].
    Conte JJ; Mignon-Conte MA; Fournie GJ
    Nouv Presse Med; 1975 Jan; 04(2):91-5. PubMed ID: 1138230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Critical reflections on treatment of lupic nephropathy: comparative study of the action of corticoids, synthetic antimalarial-indomethacin combination and heparin].
    Conte J; Mignon-Conte M; Suc JM
    J Urol Nephrol (Paris); 1973; 79(4):332-50. PubMed ID: 4720125
    [No Abstract]   [Full Text] [Related]  

  • 13. [Development and long term prognosis of lupus erythematosus (apropos of 124 cases)].
    Godeau P; Betourne C; Piette JC; Herreman G; Wechsler B; Levy R
    Ann Med Interne (Paris); 1977 Jan; 128(1):17-30. PubMed ID: 855968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lupus nephritis: retrospective analysis of the course of the disease].
    Djukanović L; Pavlović S; Blagojević R; Dimitrijević J; Stojsic T; Ratković M; Kazić K; Lezaić V; Naumović R
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():26-31. PubMed ID: 12583310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing histopathology patterns in lupus nephropathy.
    Mahajan SK; Ordónez NG; Spargo BH; Katz AI
    Clin Nephrol; 1978 Jul; 10(1):1-8. PubMed ID: 699393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of systemic lupus erythematosus].
    Marmont A
    Recenti Prog Med; 1966 Jun; 40(6):473-523. PubMed ID: 6014403
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative evaluation of the effectiveness of diverse variants of drug therapy in chronic glomerulonephritis].
    Popova LA
    Ter Arkh; 1979; 51(1):77-83. PubMed ID: 432837
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus V: lupus nephritis.
    Blotzer JW
    Md State Med J; 1983 Nov; 32(11):851-6. PubMed ID: 6361395
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunofluorescent microscopic findings in glomerulonephritis.
    Tabassum S; Rahman KM; Mamun KZ; Ahmed AN; Islam KM; Rahman H
    Bangladesh Med Res Counc Bull; 1997 Dec; 23(3):77-81. PubMed ID: 9621476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.